Abstract CT139: A phase I study of HG146: A novel selective HDAC inhibitor, as single-agent in patients with advanced solid tumors and lymphomas
Year: 2025
Type: conference-abstract
Source: Cancer Research
Author: Xiaodong Huang
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4409822256